Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
REGNRegeneron Pharmaceuticals	$56.25bn	12.62	n/a
SGENSeagen	$43.15bn	n/a	n/a
IQVIqvia Holdings	$27.24bn	20.39	n/a
BNTXBioNTech SE	$25.65bn	n/a	n/a
INSMInsmed	$18.87bn	n/a	n/a
SMMTSummit Therapeutics	$15.30bn	n/a	n/a
KRTXKaruna Therapeutics	$12.58bn	n/a	n/a
EXELExelixis	$11.91bn	18.65	n/a
TEMTempus AI	$11.52bn	n/a	n/a
ICLRIcon	$11.49bn	13.47	n/a
MRNAModerna	$10.50bn	n/a	n/a
ASNDAscendis Pharma A/S	$10.50bn	n/a	n/a
QGENQiagen NV	$10.34bn	28.69	n/a
EXASExact Sciences	$10.12bn	n/a	n/a
RXDXPrometheus Biosciences	$9.56bn	n/a	n/a
MEDPMedpace Holdings	$8.93bn	23.71	n/a
IMGNImmunoGen	$8.72bn	n/a	n/a
RGCRegencell Bioscience Holdings	$8.60bn	n/a	n/a
BPMCBlueprint Medicines	$8.28bn	n/a	n/a
CERECerevel Therapeutics Holdings	$8.19bn	n/a	n/a